TY - JOUR
T1 - Natural killer cells for osteosarcoma
AU - Tarek, Nidale
AU - Lee, Dean A.
N1 - Publisher Copyright:
© Springer International Publishing Switzerland 2014.
PY - 2014
Y1 - 2014
N2 - Natural killer (NK) cells are lymphocytes of the innate immune system that have the ability to recognize malignant cells through detection of a variety of cell-surface indicators of stress and danger. Once activated through such recognition, NK cells release cytokines and induce target cell lysis through a variety of mechanisms. NK cells are increasingly recognized as important mediators of other immu-notherapeutic modalities, including cytokines, antibodies, immunomodulators, and stem cell transplantation. Adoptive immunotherapies with NK cells are being tested in early-stage clinical trials, and recent advances in manipulating their number and function have caused a renewed emphasis on this cancer-fi ghting cell. In this chapter we address the evidence for NK cell recognition of osteosarcoma in vitro and in vivo, discuss new therapies that are directly or indirectly dependent on NK cell function, and describe potential approaches for manipulating NK cell number and function to enhance therapy against osteosarcoma.
AB - Natural killer (NK) cells are lymphocytes of the innate immune system that have the ability to recognize malignant cells through detection of a variety of cell-surface indicators of stress and danger. Once activated through such recognition, NK cells release cytokines and induce target cell lysis through a variety of mechanisms. NK cells are increasingly recognized as important mediators of other immu-notherapeutic modalities, including cytokines, antibodies, immunomodulators, and stem cell transplantation. Adoptive immunotherapies with NK cells are being tested in early-stage clinical trials, and recent advances in manipulating their number and function have caused a renewed emphasis on this cancer-fi ghting cell. In this chapter we address the evidence for NK cell recognition of osteosarcoma in vitro and in vivo, discuss new therapies that are directly or indirectly dependent on NK cell function, and describe potential approaches for manipulating NK cell number and function to enhance therapy against osteosarcoma.
KW - Adoptive immunotherapy
KW - Immunomodulation
KW - Monoclonal antibodies
KW - NKG2D
KW - Natural killer cells
UR - http://www.scopus.com/inward/record.url?scp=84907168734&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84907168734&partnerID=8YFLogxK
U2 - 10.1007/978-3-319-04843-7_19
DO - 10.1007/978-3-319-04843-7_19
M3 - Article
C2 - 24924184
AN - SCOPUS:84907168734
SN - 0065-2598
VL - 804
SP - 341
EP - 353
JO - Advances in experimental medicine and biology
JF - Advances in experimental medicine and biology
ER -